Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (October, 10.1007/s11523-020-00757-3, 2020)

Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (October, 10.1007/s11523-020-00757-3, 2020)

An Online First version of this article was made available online at on 12 October 2020. Errors were subsequently identified in the article, and the following corrections should be noted.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Targeted oncology 2020-12, Vol.15 (6), p.809-810
Hauptverfasser: Orsi, Giulia, Tovoli, Francesco, Dadduzio, Vincenzo, Vivaldi, Caterina, Brunetti, Oronzo, Ielasi, Luca, Conti, Fabio, Rovesti, Giulia, Gramantieri, Laura, Rizzato, Mario Domenico, Pecora, Irene, Argentiero, Antonella, Teglia, Federica, Lonardi, Sara, Salani, Francesca, Granito, Alessandro, Zagonel, Vittorina, Marisi, Giorgia, Cabibbo, Giuseppe, Foschi, Francesco Giuseppe, Benevento, Francesca, Cucchetti, Alessandro, Piscaglia, Fabio, Cascinu, Stefano, Scartozzi, Mario, Casadei-Gardini, Andrea
Format: Artikel
Sprache:eng
Schlagworte:
Life Sciences & Biomedicine
Oncology
Science & Technology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:An Online First version of this article was made available online at on 12 October 2020. Errors were subsequently identified in the article, and the following corrections should be noted.
ISSN:1776-2596
1776-260X
DOI:10.1007/s11523-020-00765-3